Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04294901 · ClinicalTrials.gov registry record · NA
Engaging Patients to Promote Deprescribing
A NA study of Deprescriptions and Medical Overuse, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 5,946
- Enrollment target
- 4
- Study locations
NCT04294901 is a NA study of Deprescriptions and Medical Overuse that has completed, run by VA Office of Research and Development. The registered enrollment target is 5,946 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT04294901, a NA study of Deprescriptions and Medical Overuse, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,946 participants
- Enrollment target
- 4
- Study locations
Study Summary
One mechanism to reduce potentially inappropriate medications is through deprescribing, a deimplementation-based approach to thoughtfully discontinue a medication a patient is currently prescribed. Many interventions to overcome deprescribing barriers target the provider, who is already overburdened. Although some believe providers have primary responsibility for deprescribing, patient-initiated discontinuation discussions can effectively facilitate deprescribing. In a single-site pilot study, the investigators successfully engaged VA Primary Care patients to facilitate deprescribing of select potentially inappropriate medications. The investigators now propose a multisite randomized controlled trial of engaging Veterans who may be deprescribing candidates. By study end, the investigators will have established the effectiveness of an innovative, low-tech, patient-focused intervention to promote deprescribing, thereby directly improving quality, safety, and value of VA care while also setting the stage for generalization of this approach to other potentially inappropriate medications.
Conditions Studied
Interventions
- BEHAVIORAL Direct to patient medication brochure
Study Locations (4)
Massachusetts
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston
- VA Central Western Massachusetts Healthcare System, Leeds, MA - Leeds
California
- San Francisco VA Medical Center, San Francisco, CA - San Francisco
New York
- James J. Peters VA Medical Center, Bronx, NY - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,946 participants |
| Start Date | 2021-03-29 |
| Est. Completion | 2023-10-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04294901
The ClinicalTrials.gov registry entry for NCT04294901 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5,946 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Deprescriptions appearing as the primary indexed condition, and to 1 intervention - of which Direct to patient medication brochure is the first listed.
NCT04294901 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, California, New York.
Frequently Asked Questions
What is clinical trial NCT04294901 about?
NCT04294901 is a clinical study titled "Engaging Patients to Promote Deprescribing". One mechanism to reduce potentially inappropriate medications is through deprescribing, a deimplementation-based approach to thoughtfully discontinue a medication a patient is currently prescribed. Many interventions to overcome deprescribing barriers target the provider, who is already overburdened...
What is the current status of trial NCT04294901?
This trial is currently completed. It is a NA study. The enrollment target is 5,946 participants. The study started on 2021-03-29. Estimated completion is 2023-10-07.
What conditions does trial NCT04294901 study?
This clinical trial studies the following conditions: Deprescriptions, Medical Overuse, Inappropriate Prescribing.
What interventions are being tested in trial NCT04294901?
The interventions under investigation include: Direct to patient medication brochure (BEHAVIORAL).
Who is sponsoring clinical trial NCT04294901?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04294901 being conducted?
This trial has 4 study locations across California, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Deprescriptions
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.